SMTL ID : 3ciu.1

Site-Selective Glycosylation of Cysteine-93 beta on the Surface of Bovine Hemoglobin and its Application as a Novel Oxygen Therapeutic

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

hetero-2-2-mer

Ligands

4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)(Non-covalent)

HEM.1: 19 residues within 4Å: Chain A: M.32, Y.42, F.43, H.45, F.46, H.58, K.61, V.62, A.65, L.83, L.86, H.87, L.91, N.97, F.98, L.101, V.132, L.136 Ligands: O.2 17 PLIP interactions: 16 interactions with chain A, 1 Ligand-Ligand interactions Hydrophobic interactions: A:F.43, A:K.61, A:V.62, A:A.65, A:L.83, A:L.86, A:L.91, A:F.98, A:L.101, A:L.101, A:V.132, A:L.136 Salt bridges: A:H.45, A:H.58, A:K.61 Metal complexes: A:H.87, O.2 HEM.3: 19 residues within 4Å: Chain B: T.37, F.40, F.41, F.44, H.62, K.65, V.66, S.69, F.84, L.87, L.90, H.91, L.95, V.97, N.101, F.102, L.105, L.140 Ligands: O.4 13 PLIP interactions: 12 interactions with chain B, 1 Ligand-Ligand interactions Hydrophobic interactions: B:F.40, B:F.84, B:L.87, B:L.90, B:L.95, B:V.97, B:V.97, B:N.101, B:F.102, B:L.140 Salt bridges: B:H.62 Metal complexes: B:H.91, O.4 HEM.6: 19 residues within 4Å: Chain C: M.32, Y.42, F.43, H.45, F.46, H.58, K.61, V.62, A.65, L.83, L.86, H.87, L.91, V.93, N.97, F.98, L.101, L.136 Ligands: O.7 18 PLIP interactions: 17 interactions with chain C, 1 Ligand-Ligand interactions Hydrophobic interactions: C:Y.42, C:F.43, C:F.43, C:F.46, C:K.61, C:A.65, C:L.83, C:L.91, C:V.93, C:V.93, C:N.97, C:L.101, C:L.136 Salt bridges: C:H.45, C:H.58, C:K.61 Metal complexes: C:H.87, O.7 HEM.8: 18 residues within 4Å: Chain D: L.30, T.37, F.40, F.41, H.62, K.65, V.66, S.69, F.70, L.87, H.91, L.95, V.97, N.101, F.102, L.105, L.140 Ligands: O.9 18 PLIP interactions: 17 interactions with chain D, 1 Ligand-Ligand interactions Hydrophobic interactions: D:L.30, D:F.40, D:F.40, D:F.41, D:F.41, D:V.66, D:F.70, D:F.70, D:L.95, D:L.95, D:V.97, D:V.97, D:N.101, D:F.102, D:L.105, D:L.140 Salt bridges: D:H.62 Metal complexes: O.9

4 x O: OXYGEN ATOM(Non-covalent)

O.2: 2 residues within 4Å: Chain A: H.58 Ligands: HEM.1 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.58 O.4: 4 residues within 4Å: Chain B: F.41, H.62, V.66 Ligands: HEM.3 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:H.62 O.7: 2 residues within 4Å: Chain C: F.43 Ligands: HEM.6 No protein-ligand interaction detected (PLIP) O.9: 3 residues within 4Å: Chain D: F.41, H.62 Ligands: HEM.8 No protein-ligand interaction detected (PLIP)

1 x 5DP: 5-(2,5-dioxopyrrolidin-1-yl)-N-[2-(2-{2-[(4-O-alpha-D-idopyranosyl-alpha-D-mannopyranosyl)oxy]ethoxy}ethoxy)ethyl]pentanamide(Covalent)

5DP.5: 2 residues within 4Å: Chain B: C.92, D.93 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:D.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bhatt, V.S. et al., Site-Selective Glycosylation of Cysteine-93 beta on the Surface of Bovine Hemoglobin and its Application as a Novel Oxygen Therapeutic. To be Published

Release Date

2008-04-15

Peptides

Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Hemoglobin subunit alpha

Hemoglobin subunit beta

Related Entries With Identical Sequence